Jiangxi Institute of Biological Products Inc. Class H 6915

HKEX · Hong Kong SAR China · Health Technology

HKD 11.30+0.73 (+6.91%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Jiangxi Institute of Biological Products Inc. Class H 6915

HKEX · Hong Kong SAR China · Health Technology

HKD 11.30+0.73 (+6.91%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+15.54% · 6MFull-screen chart

Open HKD 10.50High HKD 11.30Low HKD 9.67Close HKD 11.30Volume 1.06M

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 10.57
Day range: HKD 9.67 – HKD 11.30
52-week range: HKD 3.95 – HKD 21.10
Volume: 1.06M
Market cap: HKD 3.26B
P/E (last fiscal year): 33.0
Next earnings date: 2027-03-03
Avg. volume (1Y): 2.09M

Performance

1 week

-6.61%

1 month

-36.66%

3 months

+116.89%

6 months

+15.54%

Year to date

+15.54%

1 year

+15.54%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 307.09M
Employees: 327
ISIN: CNE100007Q61
Beta: 4.65

Technical view

Not enough data

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJul 27, 2026

Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio

Jiangxi Institute of Biological Products Inc. and its subsidiaries (collectively, "Jiangxi Bio" or the "Group") (stock code: 6915.HK) is pleased to announce that the veterinary tetanus antitoxin ("Veterinary TAT") production line of Chifeng Bo-en Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the Group, officially commenced production on July 20, 2026 in Chifeng City, Inner Mongolia Autonomous Region.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.